Nicotine improves delayed recognition in schizophrenic patients
- First Online:
- 161 Downloads
Nicotine has been shown to enhance some aspects of memory, attention and cognition in normal subjects and in some patient populations such as Alzheimer’s and Parkinson’s disease groups.
Memory disorders are consistently observed in schizophrenic patients, so it is of interest to determine whether nicotine might improve memory performance in these patients.
Delayed recognition was assessed using yes/no recognition of visuospatial designs. Working memory was assessed in a delayed match-to-sample paradigm using unfamiliar faces. Nicotine (1.0 mg delivered via nasal spray) was administered to schizophrenic patients and normal volunteers prior to testing in the nicotine condition. Results were compared to a baseline condition in which no nicotine was given.
On both tasks, normal volunteers performed better overall than schizophrenic patients. Significant improvement following nicotine administration was obtained only on the delayed recognition task and only for the subset of schizophrenic patients who were smokers. This improvement reflected a reduction in false alarm rates in the nicotine condition; hit rates were unaffected by nicotine.
These results suggest that nicotine enhances delayed recognition memory in schizophrenic patients who smoke, but that similar performance enhancement is not observed for working memory.
KeywordsNicotine Schizophrenia Delayed recognition Working memory
- American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Arlington, Va.Google Scholar
- Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, Myles-Worsley M, Nagamoto HT, Rose G, Waldo M (1994) Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2:179–192Google Scholar
- Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587–592PubMedGoogle Scholar
- Haxby JV, Ungerleider LG, Horwitz B, Rapoport SI, Grady CL (1995) Hemispheric differences in neural systems for face working memory: a PET-rCBF study. Hum Brain Map 3:68–82Google Scholar
- Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 2:345–395Google Scholar
- Hindmarch I, Sherwood N (1995) Nicotine and cognitive effects. In: Clarke PBS, Quik M, Thurau K (eds) Advances in pharmacological sciences: effects of nicotine on biological systems, II. Birkhauser Verlag, Basel, pp 189–194Google Scholar
- Joseph MH, Peters SL, Gray JA (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110:187–192Google Scholar
- Klein C, Andresen B (1991) On the influence of smoking upon smooth pursuit eye movements of schizophrenics and normal controls. J Psychophysiol 5:361–369Google Scholar
- Ksir C (1992) Behavioral neuropharmacology of nicotine. In: Watson RR (ed) Drugs of abuse and neurobiology. CRC Press, Boca Raton, Fla., pp 131–148Google Scholar
- Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG (1996) Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer’s disease: a pilot double blind transdermal nicotine positron emission tomography study. Neuropsychol Rev 6:61–79PubMedGoogle Scholar
- Peters R, McGee R (1982) Cigarette smoking and state-dependent memory. Psychopharmacology 76:232–235Google Scholar
- Rusted JM, Graupner L, Warburton DM (1995) Effects of post-trial administration of nicotine on human memory: evaluating the conditions for improving memory. Psychopharmacology 119:405–413Google Scholar
- Spitzer RL, Endicott JE (1995) The structured clinical interview for DSM-IV. American Psychiatric Press, Washington D.C.Google Scholar